Feasibility Study of CBCT for IGRT in Cancer Patients

Cone beam computed tomography (CBCT) is an imaging technology that is incorporated into many modern radiation therapy systems. The quality of conventional CBCT is good enough to align patients for their daily radiation therapy but CBCT images have poor contrast and are susceptible to imaging artefacts that limit their usability for other tasks in the radiation therapy workflow. Varian Medical Systems, the sponsor of this study, has developed new CBCT imaging technology called HyperSight that so far has demonstrated increased image quality compared with conventional CBCT images. This new Hyper

Trial Details

NCT ID
NCT06681233
Phase
NA
Sponsor
Varian, a Siemens Healthineers Company
Status
RECRUITING
Cancer Type
Liver Cancer
Interventions
  • Comparison of HyperSight CBCT imaging to conventional CBCT imaging.
Locations (sample)
  • Columbus, Ohio, United States|39.96118,-82.99879
  • Columbus, Ohio, United States|39.96118,-82.99879
  • Columbus, Ohio, United States|39.96118,-82.99879
  • Columbus, Ohio, United States|39.96118,-82.99879

Key Eligibility Criteria

  • Patient age ≥ 18
  • Patient is receiving radiation therapy for head and neck, thorax, liver, breast, genitourinary, or gastrointestinal malignancies
  • A CBCT acquisition for localization is standard of care for the radiation therapy treatment plan being delivered

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Liver Cancer Trials on Trialify →